Neuraxis Director increases holdings with $0.8M stock purchase

Rhea-AI Filing Summary

Neuraxis, Inc. (NRXS) Form 4 filing shows Director and 10% owner Brian P. Hannasch purchased 355,556 common shares on 07/01/2025 at $2.25 per share, an estimated cash outlay of roughly $0.8 million. The transaction was coded “P” (open-market purchase), executed directly, and lifts Hannasch’s total direct holdings to 1,131,522 shares.

Key take-aways:

• The purchase represents a sizable vote of confidence by a control insider.
• Post-transaction ownership exceeds one million shares, reinforcing alignment with minority shareholders.
• No disposals or derivative transactions were reported.

The filing contains no additional financial data or explanatory notes beyond the standard certification.

Positive

• Substantial insider purchase: 355,556 shares acquired, indicating confidence from a key insider.
• Ownership increase: Beneficial holdings rise to 1,131,522 shares, strengthening alignment with shareholders.

Negative

• None.

Insights

Securities Analyst

TL;DR: Large insider buy by 10% owner signals confidence; increases direct stake to 1.13 M shares, no negative flags.

The 355,556-share purchase at $2.25 adds about $0.80 M to Mr. Hannasch’s exposure, taking his stake above the psychological one-million-share mark. Given his dual role as Director and 10% holder, the move suggests conviction in NRXS’s near-term outlook and improves governance alignment. No sales or hedges were disclosed, limiting concerns over liquidity or mixed signals. From a market-psychology standpoint, substantial insider accumulation often precedes positive price action, although causality is never guaranteed.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hannasch Brian

(Last) (First) (Middle)

8815 W. STATE ROAD 46

(Street)

COLUMBUS IN 47201

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Neuraxis, INC [ NRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2025		P		355,556	A	$2.25	1,131,522	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Griffin D. Foster, Attorney-in-fact for Brian P. Hannasch	07/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Neuraxis (NRXS) shares did Brian Hannasch purchase?

355,556 common shares were bought on 07/01/2025.

At what price were the NRXS shares acquired?

The shares were purchased at $2.25 per share.

What is Brian Hannasch’s total ownership after the transaction?

He now directly holds 1,131,522 NRXS shares.

Was the transaction a purchase or sale?

It was coded “P”, indicating an open-market purchase.

Did the Form 4 list any derivative transactions?

No, no derivative securities were reported.